Skip to main content

Table 4 Diagnostic value of FibroTest for predicting Fibrosis in all patients

From: Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

Cut-off of

FibroTest

Sensitivity

Specificity

Positive Predictive

Value

Negative Predictive

Value

Stage F2F3F4

Prevalence = 0.27

0.30

0.77 (55/71)

0.77 (150/196)

0.54 (55/101)

0.90 (150/166)

0.70

0.15 (11/71)

0.98 (192/196)

0.73 (11/15)

0.76 (192/252)

Stage F3F4

Prevalence = 0.13

0.30

0.92 (33/36)

0.71 (163/231)

0.33 (33/101)

0.98 (163/169)

0.70

0.25 (9/36)

0.97 (225/252)

0.60 (9/15)

0.89 (225/252)

% of patients with FT between 0.30–0.70

0.33 (88/267)